Pharmaceutical Chemistry Journal

, Volume 19, Issue 11, pp 747–761 | Cite as

Agents for the treatment of cardiovascular diseases

I. Antiarrhythmics (survey)
  • L. N. Yakhonmov
  • S. S. Liberman
The Search for New Drugs
  • 14 Downloads

Keywords

Cardiovascular Disease Organic Chemistry 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literature cited

  1. 1.
    Yu. V. Anshelevich and T. A. Sorokina, Kardiologiya, No. 10, 54–57 (1980).Google Scholar
  2. 2.
    V. A. Bondarenko, K. A. Zaitseva, E. E. Mikhlina, et al., Khim.-farm. Zh., No, 11, 56–60 (1978).Google Scholar
  3. 3.
    V. R. Briskin and V. G. Storozhuk, Kardiologiya, No. 10, 103–105 (1981).Google Scholar
  4. 4.
    B. E. Votchal, I. P. Zamotaev, L. G. Lozinskii, et al., Ter. Arkh., No. 8, 10–14 (1973).Google Scholar
  5. 5.
    B. E. Votchal and L. G. Lozinskii, Klin. Med., No. 10, 16–21 (1971).Google Scholar
  6. 6.
    É. I. Gendenshtein, Farmakol. Toksikol, No. 3, 303–305 (1970).Google Scholar
  7. 7.
    S. P. Golitsyn and S. F. Sokolov, Kardiologiya, No. 11, 5–8 (1983).Google Scholar
  8. 8.
    E. T. Gneushev, A. K. Starodubtsev, A. P. Kurapov, et al., Farmakol. Toksikol., No. 3, 107–110 (1982).Google Scholar
  9. 9.
    V. S. Gurevich and N. I. Razumoyskaya, Ibid., No. 10, 114–119 (1984).Google Scholar
  10. 10.
    V. L. Doshchitsyn, Kardiologiya, No. 9, 80–86 (1970).Google Scholar
  11. 11.
    V. L. Doschitsyn, Ibid., No. 1, 30–37 (1975).Google Scholar
  12. 12.
    M. A. Dumpis and N. I. Kudryashova, Khim.-farm. Zh., No. 10, 1159–1169 (1983).Google Scholar
  13. 13.
    S. V. Zhuravlev and A. N. Gritsenko, Zh. Obshch. Khim.,26, 3385–3391 (1956).Google Scholar
  14. 14.
    I. P. Zamotaev, L. G. Lozinskii, and B. L. Sandomirskii, Kardiologiya, No. 8, 93–97 (1974).Google Scholar
  15. 15.
    R. M. Zaslavskaya, I. F. Skorobogataya, and É. Ya. Kolbanovskaya, Sov. Med., No. 5, 59–62 (1969).Google Scholar
  16. 16.
    N. V. Kaverina, Z. P. Senova, Yu. I. Vikhlyaev, and O. V. Ul'yanova, Farmakol. Toksikol., No. 6, 693–698 (1970).Google Scholar
  17. 17.
    N. V. Kaverina, Z. P. Senova, V. S. Mitrofanov, and M. F. Runova, Ibid., No. 2, 182–185 (1972).Google Scholar
  18. 18.
    N. V. Kaverina, A. P. Skoldinov, M. M. Dzhaparidze, et al., Ibid., No. 5, 25–28 (1984).Google Scholar
  19. 19.
    D. F. Kesler, Klin, Med., No. 8, 63–64 (1973).Google Scholar
  20. 20.
    V. G. Kukes, A. S. Smetnev, E. L. Ponomarenko, et al., Kardiologiya, No. 11, 45–47 (1983).Google Scholar
  21. 21.
    R. D. Kurbanov and N. A. Mazur, Ibid., No. 10, 59–64 (1981).Google Scholar
  22. 22.
    M. S. Kushakovskii, Ibid., No. 5, 5–9 (1984).Google Scholar
  23. 23.
    V. P. Lanskii, Farmakol. Toksikol., No. 5, 550–553 (1973).Google Scholar
  24. 24.
    Ts. A. Levina, A. I. Romanovskaya, and A. V. Konovalenko, Kardiologiya, No. 4, 142–143 (1973).Google Scholar
  25. 25.
    N. A. Mazur, Ibid., No. 4, 5–12 (1978).Google Scholar
  26. 26.
    N. A. Mazur, Klin, Med., No. 5, 68–72 (1982).Google Scholar
  27. 27.
    N. A. Mazur and V. I. Metelitsa, Farmakol. Toksikol., No. 3, 59–61 (1982).Google Scholar
  28. 28.
    M. D. Mashkovskii, Drugs [in Russian], 9th Edn., Moscow (1984), pp. 293–301, 400–403.Google Scholar
  29. 29.
    V. I. Metelitsa, Cardiologist's Handbook of Clinical Pharmacology [in Russian], Moscow (1980), p. 85.Google Scholar
  30. 30.
    E. E. Mikhlina, V. Ya. Vorob'eva, N. A. Komarova, et al., Khim.-farm. Zh., No. 2, 24–26 (1974).Google Scholar
  31. 31.
    New Data on the Pharmacology and Clinic of Phenothiazine Derivatives [in Russian], Moscow (1958).Google Scholar
  32. 32.
    L. I. Ol'binskaya, M. S. Yurina, P. F. Litvitskii, and V. A. Sandrikov, Kardiologiya, No. 12, 10–13 (1980).Google Scholar
  33. 33.
    V. M. Orlov, V. A. Kruglov, I. R. Nikolaevskii, et al., Klin. Med., No. 1, 57–59 (1982).Google Scholar
  34. 34.
    O. S. Ryabokon', V. K. Piotrovskii, E. B. Smirnova, et al., Kardiologiya, No. 10, 40–42 (1980).Google Scholar
  35. 35.
    M. E. Raiskina, Ibid., No. 1, 141–149 (1974).Google Scholar
  36. 36.
    L. V. Rozenshtraukh, N. V. Kaverina, E. P. Anyukhovskii, et al., Ibid., No. 6, 72–81 (1982).Google Scholar
  37. 37.
    A. S. Smetnev, Kh. Kh. Shugushev, A. V. Rozenshtraukh, et al., Ter. Arkh., No. 1, 92–95 (1983).Google Scholar
  38. 38.
    A. V. Sumarokov and A. A. Mikhailov, Heart Arrhythmias [in Russian], Moscow (1976).Google Scholar
  39. 39.
    N. I. Tatishvili, Z. K. Chkhaidze, B. E. Valiev, et al., in: Problems of Clinical and Experimental Pharmacology and Side Effects of Drugs [in Russian], Tbilisi (1983), pp. 111–112.Google Scholar
  40. 40.
    D. A. Kharkevich, ed., Advances in the Creation of New Drugs [in Russian], Moscow (1973).Google Scholar
  41. 41.
    A. P. Tsybusov, Antiarrhythmic Activity of Quaternary Derivatives of Trimecaine. Author's Abstract of Dissertation for the Degree of Candidate of Medical Sciences [in Russian], Yaroslavl' (1981).Google Scholar
  42. 42.
    E. I. Chazov, Ter. Arkh., No. 5, 33–44 (1975).Google Scholar
  43. 43.
    E. S. Charnaya and E. T. Beer, Klin. Med., No. 11, 95–96 (1979).Google Scholar
  44. 44.
    Kh. Kh. Shchugushev, A. S. Smetnev, A. V. Pozenshtraukh, et al., Kardiologiya, No. 5, 71–75 (1982).Google Scholar
  45. 45.
    Kh. Kh. Shchugushev, A. S. Smetnev, and A. V. Raushenbakh, Ibid., No. 11, 72–78.Google Scholar
  46. 46.
    S. D. Yuzhakov, Khim.-farm. Zh., No. 5, 68–72 (1980).Google Scholar
  47. 47.
    Z. I. Yanushkevichus, Kardiologiya, No. 2, 35–41 (1980).Google Scholar
  48. 48.
    L. N. Yakhontov, M. D. Mashkovskii, and E. E. Mikhlina, Khim.-farm. Zh., No. 12, 23–32 (1980).Google Scholar
  49. 49.
    G. Aberg, B. Ekenstam, and E. Smith, Arzneimittel-Forsch.,33, 706–710 (1983).Google Scholar
  50. 50.
    H. J. Adams, G. H. Kronberg, and B. N. Takman, J. Pharm. Sci.,62, 1677–1679 (1973).Google Scholar
  51. 51.
    G. W. Adelstein, J. Med. Chem.,16, 309–312 (1973).Google Scholar
  52. 52.
    J. L. Anderson, D. C. Harrison, P. J. Meffin, and R. A. Vinkle, Drugs,15, 271–309 (1978).Google Scholar
  53. 53.
    J. D. Allen and A. H. Deering, J. Cardiovasc. Pharmacol.,5, 937 (1983).Google Scholar
  54. 54.
    J. D. Allen, J. M. Kofi, R. G. Shanks, et al., Brit. J. Pharmacol.,39, 183p-184p (1970).Google Scholar
  55. 55.
    Ann. Drug Data Rep., 306 (1971).Google Scholar
  56. 56.
    Ibid., p. 365.Google Scholar
  57. 57.
    Ibid., p. 387.Google Scholar
  58. 58.
    Ibid., p. 28 (1979/1980).Google Scholar
  59. 59.
    Ibid., p. 81 (1979/1980).Google Scholar
  60. 60.
    Ibid., p. 37 (1982).Google Scholar
  61. 61.
    Ibid., p. 142.Google Scholar
  62. 62.
    Ibid., p. 224.Google Scholar
  63. 63.
    Ibid., p. 24 (1983).Google Scholar
  64. 64.
    Ibid., p. 96.Google Scholar
  65. 65.
    Ibid., p. 148.Google Scholar
  66. 66.
    Ibid.,6, Pt 1, p. 2 (1984).Google Scholar
  67. 67.
    Ibid., p. 178 (1981).Google Scholar
  68. 68.
    Ibid.,6, Pt 2, pp. 73, 92 (1984).Google Scholar
  69. 69.
    Ibid., p. 89.Google Scholar
  70. 70.
    E. E. Bagwell. T. Walle, D. E. Drayer, et al., J. Pharmacol. Exp. Ther.,197, 38–48 (1976).Google Scholar
  71. 71.
    E. N. Banitt, W. E. Coyne, J. R. Schmid, and A. Mendel, J. Med. Chem.,18, 1130–1134 (1975).Google Scholar
  72. 72.
    O. A. Beck, H. U. Lehmann, and H. Horchrein, Dtsch. Med. Wschr.,103, 1068–1072 (1978).Google Scholar
  73. 73.
    O. A. Beck, K. Kramer, R. Wolf, et al., Med. Klin.,70, 95–101 (1975).Google Scholar
  74. 74.
    O. A. Beck, H. Spielmann, E. Witt, et al., Arzneimittel.-Forsch.,30, 2172–2180 (1980).Google Scholar
  75. 75.
    O. A. Beck, E. Witt, and H. Hochrein, Z. Kardiol.,64, 179–187 (1975).Google Scholar
  76. 76.
    A. Beresewicz, B. Pytkowski, G. Sedek, and K. Zdanowski, Pol. J. Pharmacol. Pharm.,35, 223–232 (1983).Google Scholar
  77. 77.
    J. L. Bergel, T. Sulkovsky, D. R. Much, and R. L. Wendt, Arzneimittel.-Forseh,33, 1258–1268 (1983).Google Scholar
  78. 78.
    A. Berlin-Wahlen, J. C. Barkus, J. B. Keenaghan, et al., Acta Pharm. Suec.,14, 417–421 (1977).Google Scholar
  79. 79.
    C. A. Bernhardt, Ch. Condamine, H. Demarne, et al., J. Med. Chem.,23, 1102–1108 (1980).Google Scholar
  80. 80.
    S. Binecki and A. Bulacinski, Acta Pol. Pharm.,36, 13–16 (1979).Google Scholar
  81. 81.
    R. L. Blandford, J. Crampton, and H. Kudlac, Brit. Med. J.,284, 16–17 (1982).Google Scholar
  82. 82.
    W. Bleifeld, S. Effer, and W. Merz, Verh. Dtsch. Ges. Inn. Med.,74, 973–975 (1968).Google Scholar
  83. 83.
    G. Bonola, P. D. Re, M. J. Magistretti, et al., J. Med. Chem.,11, 1136–1139 (1968).Google Scholar
  84. 84.
    G. Bourgery, P. Dostert, A. Lacour, et al., Ibid.,24, 159–167 (1981).Google Scholar
  85. 85.
    B. Brise and F. Bender, Med. Mschr.,31, 412–414 (1977).Google Scholar
  86. 86.
    B. Brown and P. C. Churchill, J. Pharmacol. Exp. Ther.,225, 372–377 (1983).Google Scholar
  87. 87.
    W. R. Buckett and F. A. Marwick, Brit. J. Pharmacol.,54, 3–9 (1975).Google Scholar
  88. 88.
    W. D. Bussmann, H. J. Hanek, and M. Kaltenbach, Dtsch. Med. Wschr.,99, 2443–2445 (1974).Google Scholar
  89. 89.
    W. D. Bussmann, E. Miller, and M. Kaltenbach, Ibid.,101, 228–231 (1976).Google Scholar
  90. 90.
    E. W. Byrnes, P. D. Master, E. R. Smith, et al., J. Med. Chem.,22, 1171–1176 (1979).Google Scholar
  91. 91.
    T. J. Campbell, Vaughan, and E. M. Williams, Brit. J. Pharmacol.,76, 337–345 (1982).Google Scholar
  92. 92.
    E. Carmeliet, P. A. Y. Janssen, R. Marsboom, et al., Arch. Int. Pharmacodyn.,231, 104–130 (1978).Google Scholar
  93. 93.
    W. Chen. J. Dong, and G. Ding, Chem. Abstr., 93, 795 (1979).Google Scholar
  94. 94.
    C. Chepin, L. Kushins, E. Manson, et al., Anesthesiology,53, 23–26 (1980).Google Scholar
  95. 95.
    G. C. J. Chiou and M. A. McLanghin, Europ. J. Pharmacol.,81, 587–594 (1982).Google Scholar
  96. 96.
    C. Y. C. Chew, J. Collett, and B. N. Singh, Drugs,17, 161–181 (1979).Google Scholar
  97. 97.
    G. Cocco and C. Strozzi, Europ. J. Clin. Pharmacol.,14, 105–109 (1978).Google Scholar
  98. 98.
    P. Danilo and M. R. Rosen, Amer. Heart J.,92, 532–536 (1976).Google Scholar
  99. 99.
    R. R. Dean and D. M. Ferguson, Arch. Int. Pharmacodyn.,190, 183–189 (1971).Google Scholar
  100. 100.
    L. S. Dreifus, Z. Filip, D. M. Sexton, et al., Amer. J. Cardiol.,31, 129–133 (1973).Google Scholar
  101. 101.
    Drugs of the Future,8, 1049 (1983).Google Scholar
  102. 102.
    Ibid.,9, 34 (1984).Google Scholar
  103. 103.
    Ibid., 38.Google Scholar
  104. 104.
    Ibid., 273.Google Scholar
  105. 105.
    Drugs Today,17, 37 (1981).Google Scholar
  106. 106.
    P. Duchene-Marullar, Sciences,1, 407–409 (1980).Google Scholar
  107. 107.
    D. Duran, E. V. Platia, L. S. Griffith, et al., Clin. Pharmacol. Ther.,32, 554–561 (1982).Google Scholar
  108. 108.
    M. Eckstein and E. Hedregen, Pol. J. Pharmacol. Pharm.,32, 817–821 (1980).Google Scholar
  109. 109.
    J. D. Ehrhardt, B. Rouot, and J. Schwartz, Europ. J. Med. Chem.,13, 235 (1978).Google Scholar
  110. 110.
    G. Faust and W. Fiedler, Pharmazie,28, 345–350 (1973).Google Scholar
  111. 111.
    H. Fiechring, I. Assmann, and H. Schwela, Z. Ges. Inn. Med.,36, 779–788 (1981).Google Scholar
  112. 112.
    R. Ferrini, G. Miragoli, and G. Croce, Arzneimittel-Forsch.,20, 1074–1079 (1970).Google Scholar
  113. 113.
    W. Frey, Wien. Klin. Wschr.,55, 849–853 (1918).Google Scholar
  114. 114.
    R. Gmeiner, K. N. Choi, S. Hamspete, et al., Europ. J. Cardiol.,9, 77–86 (1979).Google Scholar
  115. 115.
    J. Hamm, E. Hunckohl, and A. Schmidt, Klin. Wschr.,48, 457–464 (1970).Google Scholar
  116. 116.
    H. J. Hapke and E. Prigge, Arznemittel.-Forsch.,26, 1849–1857 (1976).Google Scholar
  117. 117.
    A. S. Harris and R. H. Kokernot, Amer. J. Physiol.,163, 505–516 (1950).Google Scholar
  118. 118.
    M. Hollmann, E. Brode, D. Hotz, et al., Arzneimittel.-Forsch.,33, 763–770 (1983).Google Scholar
  119. 119.
    B. Holmes, R. N. Brodgen, R. C. Heel, et al., Drugs,26, 93–123 (1983).Google Scholar
  120. 120.
    S. J. Hopkins, Drugs of Future,2, 12 (1977).Google Scholar
  121. 121.
    R. I. Horwitz and A. R. Feinstein, J. A. M. A.,246, 2455 (1981).Google Scholar
  122. 122.
    K. Ito, S. Kamakura, and H. Koike, Arch. Int. Pharmacodyn.,244, 73–85 (1980).Google Scholar
  123. 123.
    E. Jänchen, H. Bechtold, W. Kasper, et al., Clin. Pharmacol. Ther.,26, 187–195 (1979).Google Scholar
  124. 124.
    J. A. M. A.,213, 1326 (1970).Google Scholar
  125. 125.
    D. K. Jung, M. M. Vohza, and I. Chu, J. Pharm. Sci.,59, 1405–1409 (1970).Google Scholar
  126. 126.
    G. Kaufmann, Schweiz. Med. Wschr.,111, 1684–1687 (1981).Google Scholar
  127. 127.
    J. Keck, Z. Naturforsch.,18B, 177–179 (1963).Google Scholar
  128. 128.
    L. D. D. Keefe, R. E. Kates, and D. C. Harrison, Drugs,22, 363–400 (1981).Google Scholar
  129. 129.
    H. Kesteloot, F. van de Werf, B. Marchandise, and R. Sluyts, Acta Cardiol. (Brux.),34, 301–309 (1979).Google Scholar
  130. 130.
    H. Kesteloot and R. Stroobandt, Arch. Int. Pharmacodyn.,230, 225–234 (1977).Google Scholar
  131. 131.
    T. Kimura, M. Endoh, N. Taira, et al., Experientia,28, 813–814 (1972).Google Scholar
  132. 132.
    W. Kobinger, C. Lillie, and L. Pichler, Naunyn Schmiedeberg's Arch. Pharmacol.,306, 255–262 (1979).Google Scholar
  133. 133.
    W. Kobinger, C. Lillie, and L. Pichler, Europ. J. Pharmacol.,58, 141–150 (1979).Google Scholar
  134. 134.
    W. Kobinger and C. Lillie, Ibid.,64, 209–220 (1981).Google Scholar
  135. 135.
    M. J. Kornet and P. A. Thio, J. Pharm. Sci.,58, 724 (1969).Google Scholar
  136. 136.
    M. J. Kornet, P. A. Thio, N. Malone, et al., Ibid.,64, 639–642 (1975).Google Scholar
  137. 137.
    R. Krähenmann and P. Heistracher, Naunyn-Schmiedeberg's Arch. Pharmacol.,311, 36R (1980).Google Scholar
  138. 138.
    K. F. Lang, H. Jast, and P. Limbourg, Z. Kardiol.,64, 389–395 (1975).Google Scholar
  139. 139.
    B. Levy and M. Wasserman, Brit. J. Pharmacol.,39, 139–147 (1970).Google Scholar
  140. 140.
    T. K. Lin, Y. W. Chien, R. R. Dean, et al., J. Med. Chem.,17, 751–753 (1974).Google Scholar
  141. 141.
    L. Liangquan, Q. Zhixiang, W. Zhimin, et al., Sci. Sin. (Engl. Ed),22, 1220 (1979).Google Scholar
  142. 142.
    B. Lown, A. M. Fakhro, W. B. Hood, Jr., et al., J.A.M.A.109, 188–198 (1967).Google Scholar
  143. 143.
    B. R. Lucchesi et al., J. Pharmacol. Exp. Ther.,199, 310–328 (1976).Google Scholar
  144. 144.
    B. R. Madan, V., Madan, V. K. Pendse, and R. S. Gupta, Arch. Int.- Pharmacodyn.,105, 53–65 (1970).Google Scholar
  145. 145.
    F. R. Mantz, J. Thorac. Surg.,5, 612–628 (1936).Google Scholar
  146. 146.
    L. C. Mark, J. J. Kayder, J. M. Steele, et al., J. Pharmacol. Exp. Ther.,102, 5–15 (1951).Google Scholar
  147. 147.
    R. J. Marshall and J. A. Ojewole, Toxicol. Appl. Pharmacol.,46, 759–768 (1978).Google Scholar
  148. 148.
    R. J. Marshall and J. R. Parratt, Brit. J. Pharmacol.,55, 359 (1975); 61, 315–317 (1977).Google Scholar
  149. 149.
    P. D. McMaster, E. W. Byrnes, H. S. Feldman, et al., J. Med. Chem.,22, 1177 (1979).Google Scholar
  150. 150.
    E. O. R. Medina, Ch. Fisch, R. Bernard, et al., Cardiology, No. 12, 86–89 (1982).Google Scholar
  151. 151.
    T. Meinertz, W. Kasper, F. Kersting, et al., Clin. Pharmacol. Ther.,26, 196–206 (1979).Google Scholar
  152. 152.
    M. Moyahara, O. Itimura, M. Yokoyama, et al., Tohoku J. Exp. Med.,97, 95–96 (1969).Google Scholar
  153. 153.
    C. M. Mokler and C. G. Van Arman, J. Pharmacol. Exp. Ther.,136, 114–124 (1962).Google Scholar
  154. 154.
    B. B. Molioy and M. I. Steinberg, Life Sci.,25, 1397 (1979).Google Scholar
  155. 155.
    M. Montochef, Coeur,5, 659–662 (1974).Google Scholar
  156. 156.
    S. E. N. Moore, J. F. Spear, L. N. Horowitz, et al., Amer. J. Cardiol.,41, 703 (1978).Google Scholar
  157. 157.
    P. H. Morgen and I. W. Mathison, J. Pharm. Sci.,65, 467–482 (1976).Google Scholar
  158. 158.
    P. H. Morgen and I. W. Mathison, Ibid., 637–648.Google Scholar
  159. 159.
    R. M. Norris, Drugs,11, 409–411 (1976).Google Scholar
  160. 160.
    P. H. Nelson, A. M. Strosberg, and K. G. Untch, J. Med. Chem.,23, 180–184 (1980).Google Scholar
  161. 161.
    P. U. Nwangwu, T. L. Holcslaw, H. Rosenberg, et al., J. Pharm. Pharmacol.,31, 488–489 (1979).Google Scholar
  162. 162.
    E. Oppenheimer, E. Kaplinsky, N. Kari, et al., Angiology,31, 410–426 (1980).Google Scholar
  163. 163.
    W. Osswald, S. Guimaraes, and J. Garrett, J. Pharmacol. Exp. Ther.,174, 315–322 (1970).Google Scholar
  164. 164.
    J. C. Pamintuan, L. S. Dreifus, and J. Watanabe, Amer. J. Cardiol.,26, 512–516 (1970).Google Scholar
  165. 165.
    I. J. Pianto and A. M. Mondear, Indian Heart J.,28, 80–85 (1976).Google Scholar
  166. 166.
    J. Piessent, H. Kesteloot, and H. D. Geest, Arzneimittel.-Forsch.,20, 355–358 (1970).Google Scholar
  167. 167.
    H. Refsun, Europ. J. Pharmacol.,33, 47 (1975).Google Scholar
  168. 168.
    D. C. Remy, W. A. Saun, E. L. Engelhardt, et al., J. Med. Chem.,18, 142–148 (1975).Google Scholar
  169. 169.
    C. P. Robinson and B. V. Rama Sastry,. Ibid.,15, 870–872 (1972).Google Scholar
  170. 170.
    R. D. Robson and H. R. Kaplan, J. Pharmacol. Exp. Ther.,175, 157–177 (1970).Google Scholar
  171. 171.
    J. J. Rosanski, L. Zaman, and A. Castellanis, Amer. J. Cardiol.,49, 621–628 (1982).Google Scholar
  172. 172.
    H. J. Rüdiger, H. Homburger, and H. Antoni, Naunyn-Schmiedeberg's Arch. Pharmacol.,317, 238–244 (1981).Google Scholar
  173. 173.
    P. C. Ruenitz and C. M. Mokler, J. Med. Chem.,20, 1668–1671 (1977).Google Scholar
  174. 174.
    L. Ryden, A. Hjalmarsaon, H. Wasir, and L. Werko, Brit. Heart J.,36, 811–821 (1974).Google Scholar
  175. 175.
    H. Sachs and B. M. Kennelly, Brit. Med. J.,2, 716–721 (1972).Google Scholar
  176. 176.
    M. Sakahashi, J. Yoshikawa, R. Akiyoshi, et al., Arrneimittel.-Forsch.,33, 215–218 (1983).Google Scholar
  177. 177.
    R. Saner, Therapie,25, 393–401 (1970).Google Scholar
  178. 178.
    W. K. A. Schapor, R. Xhoneux, A. H. M. Jagenseau, and P. A. J. Janssen, J. Pharmacol. Exp. Ther.,151, 265–274 (1966).Google Scholar
  179. 179.
    C. F. Schwender, S. Farber, C. Blaum, et al., J. Med. Chem.,13, 684–688 (1970).Google Scholar
  180. 180.
    B. N. Singh, G. Ellrodt, and C. T. Peter, Drugs,15, 169–197 (1978).Google Scholar
  181. 181.
    B. N. Singh, and O. Hauswirth, Amer, Heart J.,87, 367–383 (1974).Google Scholar
  182. 182.
    B. N. Singh and R. Jewitt, Drugs,7, 426–461 (1974).Google Scholar
  183. 183.
    B. N. Singh, K. Nadelmane, and S. H. Baky, Ibid.,25, 125–153 (1983).Google Scholar
  184. 184.
    B. N. Singh and E. M. Williams, Brit. J. Pharmacol.,38, 748–757 (1970).Google Scholar
  185. 185.
    B. N. Singh and E. M. Williams, Ibid.,44, 1–9 (1972).Google Scholar
  186. 186.
    D. N. Singer and R. E. Ten-Eick, Progr. Cardiovasc. Dis.,24, 91–96 (1981).Google Scholar
  187. 187.
    L. D. Small, H. Rosenberg, P. U. Nwangwu, et al., J. Med. Chem.,22, 1014–1016 (1979).Google Scholar
  188. 188.
    J. L. Southworth, V. A. McKusick, and E. C. Pierce, J.A.M.A.,143, 717 (1950).Google Scholar
  189. 189.
    S. Stern, H. Milvidsky, and J. B. Borman, J. Clin. Pharmacol.,11, 409–412 (1971).Google Scholar
  190. 190.
    H. Sterr, Wien. Klin. Wschr.,82, 894–899 (1970).Google Scholar
  191. 191.
    D. M. Stout, W. L. Matier, C. Barcelon-Janh, et al., J. Med. Chem.,26, 808–813 (1983).Google Scholar
  192. 192.
    C. J. Sun, X. Y. Zhang, X. Z. Yang, et al., Acta Pharm. Sin.,16, 564–570 (1981).Google Scholar
  193. 193.
    T. Sugimoto, T. Ishikawa, K. Kasena, et al., Angiology,31, 700–709 (1980).Google Scholar
  194. 194.
    I. V. Talano and D. Feerst, Arch. Intern. Med.,140, 314–315 (1980).Google Scholar
  195. 195.
    R. G. Talbot, Amer. Heart J.,89, 537–538 (1975).Google Scholar
  196. 196.
    R. G. Talbot, R. A. Clark, J. Nimmo, et al., Lancet,2, 399–403 (1973).Google Scholar
  197. 197.
    K. Theisen, Dtsch. Med. Wschr.,108, 1021–1027 (1983).Google Scholar
  198. 198.
    P. A. Tenthorey, H. J. Adams, G. H. Kronberg, and G. H. Takman, J. Med. Chem.,24, 1059–1063 (1981).Google Scholar
  199. 199.
    P. A. Tenthorey, A. J. Block, R. A. Ronfeld, et al., Ibid., 798–806.Google Scholar
  200. 200.
    P. A. Tenthorey, R. L. Rubio, H. S. Feldman, et al., Ibid.,22, 182 (1979).Google Scholar
  201. 201.
    B. Terhaag and W. Forster, Pharmazie,31, 635 (1976).Google Scholar
  202. 202.
    W. Trautwein, D. Pelzer, T. F. McDonald, and W. Osterrieder, Naunyn-Schmiedeberg's Arch. Pharmacol.,317, 228 (1981).Google Scholar
  203. 203.
    A. T. Trompler and W. D. Bussmann, Arzneimittel.-Forsch.,33, 436–439 (1983).Google Scholar
  204. 204.
    K. Van Dongen, Arch. Int. Pharmacodyn.,96, 45–48 (1953).Google Scholar
  205. 205.
    P. D. Verdouw, Arzneimittel.-Forsch.,26, 1558–1561 (1976).Google Scholar
  206. 206.
    P. D. Verdouw, H. P. A. Bom, and R. E. Bijleveed, Ibid.,33, 702–706 (1983).Google Scholar
  207. 207.
    A. P. Viana and R. Osswald, Ibid.,20, 851–853 (1970).Google Scholar
  208. 208.
    H. Vidro, M. A. Mena, and E. Hong, Ibid.,30, 12–17 (1980).Google Scholar
  209. 209.
    J. De Vries, W. T. Nauta, H. Timmerman, et al., Ibid.Arzneimittel.-Forsch.,18, 1200–1203 (1968).Google Scholar
  210. 210.
    C. Wang et al., Pharmacologist, 19, Abstr., 146 (1977).Google Scholar
  211. 211.
    E. Waterloh, H. F. Rittel, and E. Leide, Arzneimittel.-Forsch.,19, 153–159 (1969).Google Scholar
  212. 212.
    D. G. Wenzel and J. E. Kloeppel, Pharmacol. Res. Commun.,12, 863–871 (1980).Google Scholar
  213. 213.
    M. Wilhelm, P. Hedwall, and M. Meier, Experientia,23, 651–652 (1967).Google Scholar
  214. 214.
    F. A. Willins and T. E. Keys, Proc. Mayo Clin.,17, 294–296 (1942). Cited in L. S. Goodman and A. Gilman, The Pharmacological Basis of Therapeutics, 5th Edn. (1975), p. 686.Google Scholar
  215. 215.
    W. Winkler, Arzneimittel.-Forsch.,33, 279–280 (1983).Google Scholar
  216. 216.
    Ch. H. Yeh, H. S. Lowrie, and R. R. Dean, J. Med. Chem.,17, 1131–1135 (1974).Google Scholar
  217. 217.
    B. K. Yeh, P. K. Sung, and B. J. Scherlag, J. Phann. Sci.,62, 1224–1229 (1979).Google Scholar
  218. 218.
    K. Zoeten, J. C. A. Meel, J. E. Kemenade, et al., Arzneimittel.-Forsch.,33, 694–698 (1983).Google Scholar

Copyright information

© Plenum Publishing Corporation 1986

Authors and Affiliations

  • L. N. Yakhonmov
    • 1
  • S. S. Liberman
    • 1
  1. 1.S. Ordzhonikidze All-Union Chemicopharmaceutical Scientific-Research InstituteMoscow

Personalised recommendations